Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
60.6M
-
Shares change
-
-153K
-
Total reported value, excl. options
-
$8.26B
-
Value change
-
-$25.1M
-
Put/Call ratio
-
1.83
-
Number of buys
-
110
-
Number of sells
-
-87
-
Price
-
$136.38
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2024
244 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2024.
Ascendis Pharma A/S - ADR (ASND) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.6M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.1M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.96M shares), FMR LLC (4.92M shares), Artisan Partners Limited Partnership (4.3M shares), Avoro Capital Advisors LLC (4.2M shares), JANUS HENDERSON GROUP PLC (3.92M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), Capital International Investors (2.1M shares), FRANKLIN RESOURCES INC (2.08M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.78M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.